JYHZ2200202 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | License Renew | 2022-07-18 | | AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Abbvie Deutschland Gmbh & Co KG | | | view |
JYHZ2100595 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | License Renew | 2021-08-05 | | Abbvie Deutschland Gmbh & Co KG | | | view |
JYHZ2000003 | 利托那韦片 | ritonavir | Tablet | Chemical Drugs | License Renew | 2020-01-19 | AbbVie Deutschland GmbH & Co. KG | Abbvie Deutschland Gmbh & Co KG | Certificate Issued | 2020-08-06 | view |
JYHZ1700275 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | License Renew | 2017-08-21 | AbbVie Ltd. | Abbvie Ltd;Abbvie Deutschland Gmbh & Co KG | Certificate Issued | 2018-03-19 | view |
JYHS2300031 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2023-02-22 | | Hetero Labs Ltd;Hainan Sihuan Pharmaceutical Co Ltd | | | view |
JYHS2300030 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2023-02-22 | | Hetero Labs Ltd;Hainan Sihuan Pharmaceutical Co Ltd | | | view |
JYHS2300004 | 利托那韦片 | ritonavir | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2023-01-17 | | Hetero Labs Ltd;Hetero Phrma (Beijing) Co Limited | | | view |
JYHB2400141 | 奈玛特韦片/利托那韦片组合包装 | nirmatrelvir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | | | Pfizer Investment Co Ltd | | | view |
JYHB2002360 | 利托那韦片 | ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2020-11-23 | AbbVie Deutschland GmbH & Co.KG | Abbvie Deutschland Gmbh & Co KG | Certificate Issued | 2021-02-02 | view |
JYHB2001606 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2020-08-28 | AbbVie Deutschland GmbH & Co.KG | Abbvie Deutschland Gmbh & Co KG | Certificate Issued | 2020-11-24 | view |
JYHB2001605 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2020-08-28 | AbbVie Deutschland GmbH & Co.KG | Abbvie Deutschland Gmbh & Co KG | Certificate Issued | 2020-11-24 | view |
JYHB2000914 | 利托那韦片 | ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2020-06-29 | AbbVie Deutschland GmbH & Co. KG | Abbvie Deutschland Gmbh & Co KG | Filed | 2020-07-01 | view |
JYHB2000638 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2020-05-27 | AbbVie Deutschland GmbH & Co.KG | Abbvie Deutschland Gmbh & Co KG | Filed | 2020-06-09 | view |
JYHB2000637 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2020-05-27 | AbbVie Deutschland GmbH & Co.KG | Abbvie Deutschland Gmbh & Co KG | Filed | 2020-06-09 | view |
JYHB1901350 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2019-11-13 | AbbVie Deutschland GmbH & Co.KG | Abbvie Deutschland Gmbh & Co KG | Certificate Issued | 2020-01-20 | view |
JYHB1901349 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2019-11-13 | AbbVie Deutschland GmbH & Co.KG | Abbvie Deutschland Gmbh & Co KG | Certificate Issued | 2020-01-20 | view |
JYHB1901176 | 利托那韦片 | ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2019-10-15 | AbbVie Deutschland GmbH & Co. KG | Abbvie Deutschland Gmbh & Co KG | Certificate Issued | 2019-12-25 | view |
JYHB1900272 | 利托那韦片 | ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2019-03-04 | AbbVie Ltd. | Abbvie Ltd;Abbvie Deutschland Gmbh & Co KG | Certificate Issued | 2019-05-13 | view |
JYHB1900178 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2019-02-12 | AbbVie Deutschland GmbH & Co. KG | Abbvie Deutschland Gmbh & Co KG | Certificate Issued | 2019-09-23 | view |
JYHB1900177 | 洛匹那韦利托那韦片 | lopinavir;ritonavir | Tablet | Chemical Drugs | Supplementary Application | 2019-02-12 | AbbVie Deutschland GmbH & Co. KG | Abbvie Deutschland Gmbh & Co KG | Certificate Issued | 2019-09-23 | view |